GSK logo

Medical Director, Oncology Clinical Development - Lung & Head/Neck Cancers

GSK

Upper Providence, PA; Waltham, MA; London, UK; Stevenage, UK; Mississauga, ON; Zug, SwitzerlandHybridPosted 26 days ago$222,750 - $371,250/year
Full TimeDirector & AboveClinical DevelopmentPharmaceutical
Original posting ↗

Summary

The Medical Director, Oncology Clinical Development - Lung & Head/Neck Cancers is the physician within the clinical programme team, bringing medical expertise, clinical judgement, and a patient-centred perspective to the design, conduct, and interpretation of clinical studies. This role is accountable for medical monitoring and safety oversight, ensuring that patient safety and clinical integrity are maintained throughout study execution.

Job description

In This Role You Will:

  • Serve as the physician within the clinical programme team, providing medical expertise across study design, conduct, safety oversight, and data interpretation
  • Lead medical monitoring activities for clinical studies, ensuring patient safety, clinical integrity, and compliance with the protocol and regulatory requirements
  • Interpret clinical and safety data from a physician perspective, generating insights that inform study-level and programme-level decisions led by the CDL
  • Partner with the Senior Scientist and cross-functional teams to ensure medical considerations are integrated into study execution and delivery
  • Contribute medical expertise to protocol development, ensuring clinical relevance, patient safety, and feasibility within the framework defined by the CDL
  • Serve as a core member of the Clinical Matrix Team (CMT), providing the medical voice in study-level discussions and cross-functional decision-making
  • Engage with investigators and Key External Experts (KEEs) to support study conduct, scientific exchange, and external representation of the programme
  • Contribute to regulatory documents, Health Authority interactions, and scientific communications from a physician perspective

Detailed Responsibilities:

Medical Monitoring and Safety Oversight

  • Lead medical monitoring activities for assigned clinical studies, including real-time clinical decision-making on patient eligibility, protocol-related medical queries, and safety oversight
  • Conduct and oversee medical review of clinical trial data, both directly and through oversight of delegated medical review activities
  • Interpret and contextualise safety data in collaboration with pharmacovigilance, ensuring appropriate signal detection, escalation, and benefit–risk assessment at the study level
  • Participate in safety review forums, including Safety Review Team (SRT) discussions, Independent Data Monitoring Committee (IDMC) data reviews, and internal governance as required
  • Ensure medical monitoring activities are conducted in compliance with GCP, ICH guidelines, and applicable regulatory frameworks

Study Design and Execution

  • Provide medical input into protocol development, ensuring clinical relevance, patient safety, and operational feasibility within the clinical strategy defined by the CDL
  • Apply clinical judgement to support protocol implementation, addressing medical questions that arise during study conduct and ensuring consistency with the study’s scientific objectives
  • Partner with the Senior Scientist to ensure that medical considerations are fully integrated into study execution, data generation, and operational delivery
  • Contribute to the development and review of key study documents, including the Informed Consent Form (ICF), protocol deviation management plan (PDMP), and study reference manual (SRM)
  • Provide medical input into clinical data generation activities, ensuring alignment with study objectives, patient safety considerations, and the Clinical Development Plan (CDP)

Data Interpretation and Scientific Contribution

  • Interpret clinical data from a physician perspective, translating findings into insights on safety, efficacy, and patient impact that inform decision-making by the CDL
  • Contribute to study-level and programme-level data interpretation, supporting the CDL’s assessment of benefit–risk and clinical positioning
  • Contribute to the development of scientific communications, including study reports, clinical study summaries, publications, and congress materials
  • Collaborate with investigators on the evaluation and development of abstracts, posters, and manuscripts derived from clinical programme data
  • Maintain current knowledge of the asset’s biological mechanism, disease landscape, evolving treatment paradigms, and competitive environment to inform clinical interpretation

Regulatory and External Engagement

  • Contribute medical expertise to regulatory documents and Health Authority interactions, including responses to clinical and safety queries
  • Support preparation of materials for regulatory submissions, advisory boards, and external engagements, providing the physician perspective on clinical data and safety
  • Engage with Key External Experts (KEEs), investigators, and scientific collaborators to support study conduct, scientific exchange, and relationship development
  • Represent the medical perspective at cross-departmental interactions, including Integrated Evidence Team (IET) and Medical Affairs strategy discussions, as delegated by the CDL
  • Contribute to the clinical and technical diligence assessment of business development opportunities as requested

Cross-Functional Collaboration and Clinical Matrix Team

  • Serve as a core member of the Clinical Matrix Team (CMT), providing medical leadership within study execution
  • Contribute medical expertise to disease area strategy, integrated evidence planning, and Medical Affairs discussions as appropriate
  • Collaborate across functions — including Clinical Operations, Biostatistics, Regulatory, and Pharmacovigilance — to ensure alignment on study objectives, patient safety, and data quality
  • Contribute to Oncology Clinical Development-wide initiatives and workstreams

Requirements

  • MD (or equivalent medical degree) with board certification or eligibility in oncology, haematology, or a related specialty
  • Clinical experience in oncology and/or relevant therapeutic areas, with direct exposure to clinical research or drug development
  • Demonstrated experience in clinical trial conduct, including medical monitoring, safety review, and clinical data interpretation
  • Experience applying clinical judgement to support study design, patient safety, and real-time medical decision-making within a structured clinical development framework
  • Experience operating effectively within cross-functional matrix teams in a pharmaceutical, biotechnology, or academic clinical trial environment
  • Experience translating clinical data into clear insights for internal and external audiences

Benefits

  • Health care
  • Insurance benefits
  • Retirement benefits
  • Paid holidays
  • Vacation
  • Paid caregiver leave
  • Paid parental leave
  • Paid medical leave
  • Share based long term incentive program
  • Annual bonus

Company overview

GSK plc (formerly GlaxoSmithKline) is a British multinational pharmaceutical and biotechnology company headquartered in London, England. Founded in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK has grown to become one of the world's leading healthcare companies with operations in over 150 countries. The company specializes in researching, developing, and manufacturing prescription medicines, vaccines, and consumer healthcare products. GSK's therapeutic areas include respiratory diseases, HIV/AIDS, oncology, immunology, and infectious diseases. The company is particularly renowned for its vaccine portfolio and has been at the forefront of developing treatments for major global health challenges. With approximately 70,000 employees worldwide, GSK maintains a strong commitment to scientific innovation and has a significant presence in key markets including the United States, Europe, and emerging economies. The company's mission is to unite science, technology, and talent to get ahead of disease together, aiming to positively impact the health of 2.5 billion people by the end of the decade.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.